Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 13, 2015	S-3/A	Pre-effective amendment to an S-3 filing	0001193125-15-126906.pdf 0001193125-15-126906.rtf 0001193125-15-126906.xls View HTML
March 1, 2022	POS AM	Post-effective amendment to an S-Type filing	0001193125-22-061620.pdf 0001193125-22-061620.rtf 0001193125-22-061620.xls View HTML
March 1, 2022	POSASR	POSASR	0001193125-22-061326.pdf 0001193125-22-061326.rtf 0001193125-22-061326.xls View HTML
April 30, 2015	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-15-159076.pdf 0001193125-15-159076.rtf 0001193125-15-159076.xls View HTML
April 29, 2016	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-16-569284.pdf 0001193125-16-569284.rtf 0001193125-16-569284.xls View HTML
May 1, 2017	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-17-151781.pdf 0001193125-17-151781.rtf 0001193125-17-151781.xls View HTML
April 30, 2018	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-18-143058.pdf 0001193125-18-143058.rtf 0001193125-18-143058.xls View HTML
April 26, 2019	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-19-122303.pdf 0001193125-19-122303.rtf 0001193125-19-122303.xls View HTML
April 23, 2020	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-20-117181.pdf 0001193125-20-117181.rtf 0001193125-20-117181.xls View HTML
April 22, 2021	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-21-126686.pdf 0001193125-21-126686.rtf 0001193125-21-126686.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax